TD Waterhouse Canada Inc. Decreases Stock Holdings in Oscar Health, Inc. $OSCR

TD Waterhouse Canada Inc. lowered its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 64.2% during the second quarter, Holdings Channel.com reports. The firm owned 11,443 shares of the company’s stock after selling 20,547 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Oscar Health were worth $326,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its position in Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after acquiring an additional 116,430 shares during the last quarter. BIT Capital GmbH grew its holdings in Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares during the last quarter. Simplify Asset Management Inc. purchased a new position in Oscar Health in the fourth quarter worth $2,948,000. Fortis Group Advisors LLC increased its position in shares of Oscar Health by 82.9% during the fourth quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company’s stock worth $2,724,000 after purchasing an additional 86,035 shares in the last quarter. Finally, Convergence Investment Partners LLC acquired a new position in shares of Oscar Health during the first quarter worth $1,208,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Wells Fargo & Company raised their price objective on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 13th. Robert W. Baird set a $27.00 target price on Oscar Health in a research report on Friday, August 7th. Barclays increased their price target on Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. UBS Group raised their price target on Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $30.00 price target on shares of Oscar Health in a research note on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $26.22.

Oscar Health Trading Up 0.4%

NYSE:OSCR opened at $32.70 on Friday. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $34.23. The firm has a fifty day simple moving average of $30.60 and a 200-day simple moving average of $23.34. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $10.09 billion, a P/E ratio of 23.36, a PEG ratio of 0.67 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. The firm had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm’s revenue was up 70.4% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.89) EPS. On average, equities research analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, CFO Richard Blackley sold 28,869 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $907,930.05. Following the completion of the transaction, the chief financial officer directly owned 1,046,108 shares of the company’s stock, valued at approximately $32,900,096.60. This trade represents a 2.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 10,360 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $325,822.00. Following the completion of the sale, the insider owned 248,697 shares in the company, valued at $7,821,520.65. The trade was a 4.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 4,322,257 shares of company stock worth $126,818,346. 22.64% of the stock is owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.